- Home
- BEAT vs CLST Comparison
BEAT vs CLST Comparison
Compare BEAT & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- CLST
- Stock Information
- Founded
- BEAT 2015
- CLST 1922
- Country
- BEAT United States
- CLST United States
- Employees
- BEAT N/A
- CLST N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- CLST
- Sector
- BEAT Technology
- CLST
- Exchange
- BEAT Nasdaq
- CLST Nasdaq
- Market Cap
- BEAT 63.5M
- CLST 54.6M
- IPO Year
- BEAT 2021
- CLST N/A
- Fundamental
- Price
- BEAT $1.56
- CLST $14.75
- Analyst Decision
- BEAT Buy
- CLST
- Analyst Count
- BEAT 1
- CLST 0
- Target Price
- BEAT $8.00
- CLST N/A
- AVG Volume (30 Days)
- BEAT 86.1K
- CLST 10.7K
- Earning Date
- BEAT 11-13-2025
- CLST 10-23-2025
- Dividend Yield
- BEAT N/A
- CLST N/A
- EPS Growth
- BEAT N/A
- CLST N/A
- EPS
- BEAT N/A
- CLST 0.60
- Revenue
- BEAT N/A
- CLST $11,340,000.00
- Revenue This Year
- BEAT N/A
- CLST N/A
- Revenue Next Year
- BEAT $28.23
- CLST N/A
- P/E Ratio
- BEAT N/A
- CLST $24.49
- Revenue Growth
- BEAT N/A
- CLST 133.67
- 52 Week Low
- BEAT $0.91
- CLST $10.67
- 52 Week High
- BEAT $3.48
- CLST $15.30
- Technical
- Relative Strength Index (RSI)
- BEAT 44.23
- CLST 67.27
- Support Level
- BEAT $1.62
- CLST $14.00
- Resistance Level
- BEAT $1.74
- CLST $14.80
- Average True Range (ATR)
- BEAT 0.13
- CLST 0.43
- MACD
- BEAT -0.01
- CLST 0.06
- Stochastic Oscillator
- BEAT 30.88
- CLST 69.69
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.